Cargando…

Evaluation of Immunogenicity of an Inactivated SARS-CoV-2 Vaccine Prototype in vitro

Detalles Bibliográficos
Autores principales:	Hancharou, Andrei, Antonevich, N., Pozniak, T., Babrukevich, Darya, Semizhon, P., Scheslenok, E., Rynda, A., Timohina, O., Minich, Y., DuBuske, Lawrence
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Mosby, Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804389/ http://dx.doi.org/10.1016/j.jaci.2021.12.339

Ejemplares similares

SARS-CoV-2-specific T Cell Immunity after Vaccination with Sputnik V and BBIBP-CorV
por: Babrukevich, Darya, et al.
Publicado: (2022)

Characterization of T cell, B cell and Natural Killer Cell Subsets in COVID-19 Patients
por: Rynda, Alena, et al.
Publicado: (2021)

Immune Predictors of Death versus Survival in COVID-19 ICU Pneumonia Patients on Mechanical Ventilators
por: Antonevich, Natalia, et al.
Publicado: (2021)

Blood Dendritic Cells, Monocytes and Myeloid-derived Suppressor Cells in Patients with COVID-19 Associated Pneumonia
por: Hancharou, Andrei, et al.
Publicado: (2021)

P094 IMMUNOLOGIC EFFICACY OF POOLED MESENCHYMAL STEM CELLS IN PATIENTS WITH SEVERE COVID-19-ASSOCIATED PNEUMONIA
por: Rynda, A., et al.
Publicado: (2021)

TLR4 Expression on Neutrophils and Peripheral Blood Monocytes in Patients with Acute SARS-COV-2
por: Yatskov, Igor, et al.
Publicado: (2023)

Cathepsin G in Patients with SARS-Cov-2 Infection of Various Degrees of Severity
por: Beloglazov, Vladimir, et al.
Publicado: (2022)

RESISTANCE TO GLUCOCORTICOSTEROID THERAPY IN PATIENTS WITH SARS-COV-2 INFECTION WITH ELEVATED MARKERS OF ENDOTOXEMIA
por: Beloglazov, V., et al.
Publicado: (2022)

Anaphylaxis as a Manifestation of Horse Allergy
por: Gawlik, Radoslaw, et al.
Publicado: (2009)

Regular Use of Nasally Applied Methyl-cellulose Powder During the Pollen Season Protects Against Sars-Covid-2 Infections
por: Popov, Todor, et al.
Publicado: (2022)

Local Immune Responses in Placentas of Women with COVID-19 SARS Complicated Pregnancy Increase with Each Trimester
por: Yeryomenko, Galyna, et al.
Publicado: (2023)

Local Oral Immune Responses May Predict the Clinical Course of Covid 19 Infections
por: Shchurok, I., et al.
Publicado: (2023)

P096 LIPOPOLYSACCHARIDE-BINDING SYSTEMS IN PATIENTS WITH SARS-COV-19 INFECTION HAVING VARIOUS DEGREES OF SEVERITY
por: Beloglazov, V., et al.
Publicado: (2021)

Assessment of Google Trends terms reporting allergies and the grass pollen season in Ukraine
por: Kaidashev, Igor, et al.
Publicado: (2020)

A practical guide to prescribing sublingual immunotherapy tablets in North America for pediatric allergic rhinoconjunctivitis: an injection-free allergy immunotherapy option
por: Blaiss, Michael, et al.
Publicado: (2023)

Manifestations of Covid-19-associated ANCA-vasculitis
por: Lishchuk-Yakymovych, Khrystyna, et al.
Publicado: (2023)

P091 BIOMARKERS OF INFLAMMATION AND IMMUNE REGULATION IN COVID-19 PATIENTS AND COVID 19 VACCINATED INDIVIDUALS
por: Trusevich, M., et al.
Publicado: (2021)

BIOMARKERS OF CYTOKINE STORM AND INFLAMMATION IN SEPSIS, POST-COVID-19 PATIENTS AND COVID-19 VACCINATED INDIVIDUALS
por: Titov, L., et al.
Publicado: (2022)

Immunogenic properties of SARS-CoV-2 inactivated by ultraviolet light
por: Gracheva, A. V., et al.
Publicado: (2022)

Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies
por: Kandeil, Ahmed, et al.
Publicado: (2021)

Immunogenicity and reactogenicity of inactivated SARS-CoV-2 vaccines in healthy adults
por: Wu, Yufei, et al.
Publicado: (2023)

Refocus on Immunogenic Characteristics of Convalescent COVID-19 Challenged by Prototype SARS-CoV-2
por: Huang, Xiaorong, et al.
Publicado: (2023)

Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people living with HIV
por: Ao, Ling, et al.
Publicado: (2022)

Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people with gastrointestinal cancer
por: Li, Tong, et al.
Publicado: (2022)

Comparing the Immunogenicity and Protective Effects of Three MERS-CoV Inactivation Methods in Mice
por: Kim, Nayoung, et al.
Publicado: (2022)

Linear functional equations operator approach
por: Antonevich, Anatolij
Publicado: (1996)

Immunogenicity of SARS inactivated vaccine in BALB/c mice
por: Xiong, Sheng, et al.
Publicado: (2004)

Immunogenicity of Fractional Dose Inactivated Poliovirus Vaccine in India
por: Ahmad, Mohammad, et al.
Publicado: (2021)

Inactivated SARS-CoV-2 vaccines elicit immunogenicity and T-cell responses in people living with HIV
por: Lv, Zhengchao, et al.
Publicado: (2022)

Immunogenicity of Inactivated SARS-CoV-2 Vaccines in Patients With Rheumatoid Arthritis: A Case Series
por: Zhao, Ting, et al.
Publicado: (2022)

Safety and immunogenicity evaluation of inactivated whole-virus-SARS-COV-2 as emerging vaccine development in Egypt
por: Saleh, Amani A, et al.
Publicado: (2021)

Safety and Immunogenicity of Inactivated and Recombinant Protein SARS-CoV-2 Vaccines in Patients With Thyroid Cancer
por: Han, Yuling, et al.
Publicado: (2022)

Immunogenicity Evaluating of the Multivalent COVID-19 Inactivated Vaccine against the SARS-CoV-2 Variants
por: Zhang, Yuntao, et al.
Publicado: (2022)

The Quantification of Spike Proteins in the Inactivated SARS-CoV-2 Vaccines of the Prototype, Delta, and Omicron Variants by LC–MS
por: Xu, Kangwei, et al.
Publicado: (2023)

Evaluation of Different Stabilizers and Inactivating Compounds for the Enhancement of Vero Cell Rabies Vaccine Stability and Immunogenicity: In Vitro Study
por: Olayan, Ebtesam, et al.
Publicado: (2019)

Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaques
por: Yadav, Pragya D., et al.
Publicado: (2021)

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in inadvertently vaccinated healthy children
por: Fernandes, Eder Gatti, et al.
Publicado: (2021)

Immunosuppression impaired the immunogenicity of inactivated SARS-CoV-2 vaccine in non-dialysis kidney disease patients
por: Zhang, Yue-Miao, et al.
Publicado: (2022)

CoronaVac: A review of efficacy, safety, and immunogenicity of the inactivated vaccine against SARS-CoV-2
por: Jin, Lairun, et al.
Publicado: (2022)

Protection from infection or disease? Re-evaluating the broad immunogenicity of inactivated SARS-CoV-2 vaccines
por: Tan, Anthony T., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e8d7fukc21jv6ttij6bn0if2t9